BuChE-IN-20

• Target:

  NOD-like Receptor (NLR) |||Beta Amyloid|||Cholinesterase (ChE) |||Reactive Oxygen Species|||Interleukin|||ROS

• Related Pathways:

  Metabolism|||Immunology/Inflammation|||Neuroscience|||NF-?B

• Bioactivity:

  BuChE-IN-20 is a selective hBuChE inhibitor (IC50= 0.13 ?M) with the ability to cross the blood-brain barrier (BBB) . This compound, a derivative of L-Tryptophan, exhibits neuroprotective effects by inhibiting nitric oxide (NO) production and reducing reactive oxygen species (ROS) levels. It effectively suppresses the self-aggregation of amyloid-beta (A?) peptides and is applicable in Alzheimer's disease research.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C